It is conceivable that when CYP17A1 is mutated or functional impaired, it may cause long-term fluctuation of blood glucose and increase the level of free lipids, which can aggravate lipid toxicity and glucose toxicity, further increase oxidative stress, cause endothelial dysfunction. This evidence concerns the gene CYP17A1 and endothelial dysfunction.